A capital raise at the beginning of an inflection point for a company in readiness for steep growth is very sensible for all shareholders. They’re either bringing in another strategic investor or their pipeline is potentially causing them angst to keep up with manufacturing. The spare cash may not be close to the investment they need to fulfil the pipeline. The only challenge for us lowly investors is whether they will allow us to participate in the CR. Last time they did not discount the share price markedly so had minimal effect on us.
long pathway here
- Forums
- ASX - By Stock
- DRO
- Ann: Trading Halt
Ann: Trading Halt, page-10
Featured News
Add DRO (ASX) to my watchlist
(20min delay)
|
|||||
Last
80.0¢ |
Change
-0.015(1.84%) |
Mkt cap ! $697.6M |
Open | High | Low | Value | Volume |
80.0¢ | 82.0¢ | 78.0¢ | $11.80M | 14.81M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
6 | 171352 | 80.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
80.5¢ | 15000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
6 | 171352 | 0.800 |
5 | 55892 | 0.795 |
14 | 121470 | 0.790 |
8 | 73890 | 0.785 |
38 | 320150 | 0.780 |
Price($) | Vol. | No. |
---|---|---|
0.805 | 15000 | 1 |
0.810 | 89241 | 3 |
0.815 | 50000 | 1 |
0.820 | 86161 | 8 |
0.825 | 200000 | 1 |
Last trade - 16.10pm 12/11/2024 (20 minute delay) ? |
Featured News
DRO (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, CEO & MD
Michael Thurn
CEO & MD
SPONSORED BY The Market Online